Loading…

Monkeypox caused less worry than COVID-19 among the general population during the first month of the WHO Monkeypox alert: Experience from Saudi Arabia

Monkeypox re-emerged in May 2022 as another global health threat. This study assessed the public's perception, worries, and vaccine acceptance for Monkeypox and COVID-19 during the first month of WHO announcement. A large-scale, cross-sectional survey was conducted between May 27 and June 5, 20...

Full description

Saved in:
Bibliographic Details
Published in:Travel medicine and infectious disease 2022-09, Vol.49, p.102426-102426, Article 102426
Main Authors: Temsah, Mohamad-Hani, Aljamaan, Fadi, Alenezi, Shuliweeh, Alhasan, Khalid, Saddik, Basema, Al-Barag, Ahmad, Alhaboob, Ali, Bahabri, Nezar, Alshahrani, Fatimah, Alrabiaah, Abdulkarim, Alaraj, Ali, Bahkali, Feras, Alkriadees, Khaled, Jamal, Amr, Halwani, Rabih, AlZamil, Fahad, Al-Subaie, Sarah, Barry, Mazin, Memish, Ziad A., Al-Tawfiq, Jaffar A.
Format: Article
Language:English
Subjects:
Citations: Items that this one cites
Items that cite this one
Online Access:Get full text
Tags: Add Tag
No Tags, Be the first to tag this record!
Description
Summary:Monkeypox re-emerged in May 2022 as another global health threat. This study assessed the public's perception, worries, and vaccine acceptance for Monkeypox and COVID-19 during the first month of WHO announcement. A large-scale, cross-sectional survey was conducted between May 27 and June 5, 2022, in Saudi Arabia. Data were collected on sociodemographic characteristics, previous infection with COVID-19, worry levels regarding Monkeypox compared to COVID-19, awareness, and perceptions of Monkeypox, and vaccine acceptance. Among the 1546 participants, most respondents (62%) were more worried about COVID-19 than Monkeypox. Respondents aged 45 years and above and those with a university degree or higher had lower odds of agreement with Monkeypox vaccination (OR 0.871, p-value 0.006, OR 0.719, p-value
ISSN:1477-8939
1873-0442
DOI:10.1016/j.tmaid.2022.102426